Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000013

President and CEO sold 4,800 shares at $28.44 ($136,512)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-05 Sale : show line 1 in the form −4,800 $28.44 $136,512 2,223,664 I
Open-market sales · 4,800 sh · avg $28.44 · $136,512
Loading xslF345X03/wf-form4_167331845186326.xml…